Oragenics Announces Breakthrough Antibiotic Analog Generation in Intrexon Collaboration October 31, 2013
Oragenics Collaboration Demonstrates Initial Success in the Second Phase of Lantibiotics Project August 26, 2013
Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140 February 12, 2013
Oragenics Receives European Union CPNP Notifications for ProBiora3® Cosmetic Tablets February 11, 2013
Oragenics CEO To Present at The BIO CEO & Investor Conference on February 12th 2013 February 11, 2013
